John G. Clement
Keine laufenden Positionen mehr
Karriereverlauf von John G. Clement
Ehemalige bekannte Positionen von John G. Clement
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SATELLOS BIOSCIENCE INC. | Direktor/Vorstandsmitglied | 09.12.2009 | 22.07.2011 |
| Technik-/Wissenschafts-/F&E-Leiter | 09.12.2009 | 22.07.2011 | |
| Gründer | 15.02.2005 | 22.07.2011 | |
| Corporate Officer/Principal | 09.12.2009 | 09.12.2009 | |
| Canada Department of National Defence (Canada) | Corporate Officer/Principal | - | - |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Corporate Officer/Principal | - | - |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von John G. Clement
| University of Western Ontario | Doctorate Degree |
Statistik
International
| Kanada | 6 |
Operativ
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
iCo Therapeutics, Inc.
 iCo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology iCo Therapeutics, Inc. is a canadian biotechnology company. It engages in the business of identification, development and commercialization of drug candidates to treat ocular and infectious diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA. | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
| Canada Department of National Defence (Canada) | Government |
- Börse
- Insiders
- John G. Clement
- Erfahrung
